Urology
Volume 75, Issue 2 , Pages 376-381, February 2010

Adenocarcinoma Versus Urothelial Carcinoma of the Urinary Bladder: Comparison Between Pathologic Stage at Radical Cystectomy and Cancer-specific Mortality

  • Giovanni Lughezzani

      Affiliations

    • Cancer Prognosis and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
    • Department of Urology, Vita-Salute San Raffaele University, Milan, Italy
  • ,
  • Maxine Sun

      Affiliations

    • Cancer Prognosis and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
  • ,
  • Claudio Jeldres

      Affiliations

    • Cancer Prognosis and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
  • ,
  • Ahmed Alasker

      Affiliations

    • Cancer Prognosis and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
  • ,
  • Lars Budäus

      Affiliations

    • Cancer Prognosis and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
  • ,
  • Shahrokh F. Shariat

      Affiliations

    • Cancer Prognosis and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
  • ,
  • Mathieu Latour

      Affiliations

    • Department of Pathology, University of Montréal, Montreal, Quebec, Canada
  • ,
  • Hugues Widmer

      Affiliations

    • Department of Urology, University of Montréal, Montreal, Quebec, Canada
  • ,
  • Alain Duclos

      Affiliations

    • Department of Urology, University of Montréal, Montreal, Quebec, Canada
  • ,
  • Martine Jolivet-Tremblay

      Affiliations

    • Department of Urology, University of Montréal, Montreal, Quebec, Canada
  • ,
  • Francesco Montorsi

      Affiliations

    • Department of Urology, Vita-Salute San Raffaele University, Milan, Italy
  • ,
  • Paul Perrotte

      Affiliations

    • Department of Urology, University of Montréal, Montreal, Quebec, Canada
  • ,
  • Pierre I. Karakiewicz

      Affiliations

    • Cancer Prognosis and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
    • Department of Urology, University of Montréal, Montreal, Quebec, Canada
    • Corresponding Author InformationReprint requests: Pierre I. Karakiewicz, M.D., F.R.C.S.C., Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center (CHUM), 1058, Rue St.-Denis, Montréal, QC, Canada, H2X 3J4

Received 14 September 2009; accepted 15 October 2009. published online 17 December 2009.

Objectives

To compare stage at radical cystectomy (RC) and cancer-specific mortality (CSM) after RC between non-urachal adenocarcinoma (ADK) and urothelial carcinoma (UC) of the urinary bladder.

Methods

Within 17 Surveillance, Epidemiology and End Results registries, we identified ADK and UC patients who underwent a RC between 1988 and 2006. We examined differences in stage and grade at RC between ADK and UC patients. Kaplan–Meier plots depicted CSM after RC. Cox regression analyses examined CSM rates, adjusted for T and N stages, tumor grade, age, gender, race, and year of surgery. Thereafter, we relied on statistically significant variables from the multivariate Cox regression model to match ADK and UC patients. Finally, we plotted Kaplan–Meier survival curves of the matched ADK and UC patients.

Results

Of 306 ADK and 11 697 UC patients, 188 (61.4%) and 5538 (47.3%), respectively, showed extravesical disease (pT3-4; P <.001) and 26.5% vs 21.7% had lymph node metastases at RC (P = .04), respectively. After adjustment for all covariates, including stage and grade, ADK was not associated with worse prognosis than UC (hazard ratio, 1.05; P = .6). Similarly, after matching, no difference in CSM was recorded between the 2 histologic subtypes (hazard ratio, 1.07; P = .5).

Conclusions

ADK patients undergo RC at more advanced disease stages. However, stage- and grade-adjusted CSM is the same between ADK and UC patients. Efforts should be aimed at providing definitive treatment at earlier stages, especially in patients with ADK histologic subtype.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0090-4295(09)02734-4

doi:10.1016/j.urology.2009.10.018

Urology
Volume 75, Issue 2 , Pages 376-381, February 2010